/Companies

Blocksynop

2 known investors

Find your way into Blocksynop

117 people in our graph share verified history with the Blocksynop team — schools, employers, funds. One of them is your warm intro.

Blocksynop develops the Neural Blockade Monitor, a noninvasive, real-time device for measuring the effectiveness of local anesthetics (neural blocks) in patients. The tool is intended for anesthesiologists and clinical pain management, combining biomedical and systems engineering.

Founders & leadership

WSWayne Sternberger
Wayne SternbergerCTO & Co-inventor
SSShari Sternberger
Shari SternbergerPresident/CEO
EM
Ellyn MurphySenior VP, MarketingSenior VP of Marketing at Blocksynop, which develops a noninvasive neural blockade monitoring device for anesthesiologists. Murphy has held marketing leadership roles across medical devices, financial services, telecommunications, and other industries, with experience in strategic planning, product development, and international project execution in both corporate and consulting settings.
RS
Robert S. GreenbergSenior Medical Consultant & Co-inventor

Investors · 2

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2023$274.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Blocksynop do?
Blocksynop develops the Neural Blockade Monitor, a noninvasive, real-time device for measuring the effectiveness of local anesthetics (neural blocks) in patients. The tool is intended for anesthesiologists and clinical pain management, combining biomedical and systems engineering.
Who founded Blocksynop?
Blocksynop was founded by Wayne Sternberger.
Who are Blocksynop's investors?
Blocksynop's investors include Maryland TEDCO, TEDCO.